SRPT Q2 2018 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$74M+110.0% YoY

Gross Profit

$67M90.8% margin

Operating Income

-$103M-140.7% margin

Net Income

-$109M-148.6% margin

EPS (Diluted)

$-1.67

QoQ Revenue Growth

+13.8%

Cash Flow

Operating Cash Flow

-$117M

Free Cash Flow

-$127M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$548M

Stockholders' Equity

$699M

Cash & Equivalents

$410M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74M	$35M	+110.0%
Gross Profit	$67M	$34M	+93.7%
Operating Income	-$103M	-$63M	-63.3%
Net Income	-$109M	-$63M	-73.3%